9EOT image
Entry Detail
PDB ID:
9EOT
EMDB ID:
Title:
Structure of human ceramide synthase 6 (CerS6) bound to C16:0 (nanobody Nb02)
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2024-03-15
Release Date:
2024-11-13
Method Details:
Experimental Method:
Resolution:
3.02 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Isoform 2 of Ceramide synthase 6
Chain IDs:A, D (auth: C)
Chain Length:357
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Nanobody-02
Chain IDs:B, C (auth: D)
Chain Length:134
Number of Molecules:2
Biological Source:Vicugna pacos
Primary Citation
Structural basis of the mechanism and inhibition of a human ceramide synthase.
Nat.Struct.Mol.Biol. 32 431 440 (2025)
PMID: 39528795 DOI: 10.1038/s41594-024-01414-3

Abstact

Ceramides are bioactive sphingolipids crucial for regulating cellular metabolism. Ceramides and dihydroceramides are synthesized by six ceramide synthase (CerS) enzymes, each with specificity for different acyl-CoA substrates. Ceramide with a 16-carbon acyl chain (C16 ceramide) has been implicated in obesity, insulin resistance and liver disease and the C16 ceramide-synthesizing CerS6 is regarded as an attractive drug target for obesity-associated disease. Despite their importance, the molecular mechanism underlying ceramide synthesis by CerS enzymes remains poorly understood. Here we report cryo-electron microscopy structures of human CerS6, capturing covalent intermediate and product-bound states. These structures, along with biochemical characterization, reveal that CerS catalysis proceeds through a ping-pong reaction mechanism involving a covalent acyl-enzyme intermediate. Notably, the product-bound structure was obtained upon reaction with the mycotoxin fumonisin B1, yielding insights into its inhibition of CerS. These results provide a framework for understanding CerS function, selectivity and inhibition and open routes for future drug discovery.

Legend

Protein

Chemical

Disease

Primary Citation of related structures